Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Impact of guidance issued during COVID-19 to expand access to take-home dosing of opioid agonist treatment (OAT) on OAT prescribing practices in primary care in Ireland: An interrupted time series analysis" International Journal of Drug Policy, Volume 153, July 2026, 105321.

The International journal on drug policy·2026
Same author

Risk prediction models for familial breast cancer.

The Cochrane database of systematic reviews·2026
Same author

Impact of guidance issued during COVID-19 to expand access to take-home dosing of opioid agonist treatment (OAT) on OAT prescribing practices in primary care in Ireland: An interrupted time series analysis.

The International journal on drug policy·2026
Same author

Surveillance of carbapenemase-producing organisms - considering the practical and local implications of current surveillance processes.

The Journal of hospital infection·2026
Same author

Trends in primary brain tumour incidence and mortality in Ireland 1995-2019.

Irish journal of medical science·2026
Same author

Estimating the Prevalence of Prescribed Medication Use in Pregnancy with a Systematic Review and Meta-analysis.

Drug safety·2026
Same journal

Regulatory Reliance and the Politics of Pharmaceutical Governance.

American journal of public health·2026
Same journal

Community Health Workers' Perspectives on Career Advancement and Job Satisfaction: Indiana, March-August 2024.

American journal of public health·2026
Same journal

100 Years of Drinking Water Outbreak Surveillance: Trends and Influence, United States, 1920-2020.

American journal of public health·2026
Same journal

Chronic Disease-Related Social and Behavioral Risk Factors and Conditions Among Non-Hispanic American Indian and Alaska Native People: Behavioral Risk Factor Surveillance System, 2011-2023.

American journal of public health·2026
Same journal

Public Health Graduate Education as the Foundation for Responsible Artificial Intelligence Use.

American journal of public health·2026
Same journal

Embodied Truths Will Endure: On the Politics of and in Public Health.

American journal of public health·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000.

Luigi Palmieri1, Kathleen Bennett, Simona Giampaoli

  • 1National Centre of Epidemiology, Surveillance, and Promotion of Health, National Institutes of Health, 00162 Rome, Italy. luigi.palmieri@iss.it

American Journal of Public Health
|July 18, 2009
PubMed
Summary
This summary is machine-generated.

Reductions in major cardiovascular risk factors, primarily cholesterol and blood pressure, accounted for over half of the decline in coronary heart disease deaths in Italy from 1980 to 2000. Medical treatments contributed less than half to this mortality reduction.

Related Experiment Videos

Last Updated: Jun 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Area of Science:

  • Cardiovascular epidemiology
  • Public health research
  • Health economics

Background:

  • Coronary heart disease (CHD) mortality rates have shown significant declines in many developed countries.
  • Understanding the drivers of these mortality trends is crucial for effective public health policy and resource allocation.
  • Italy experienced a notable decrease in CHD mortality between 1980 and 2000.

Purpose of the Study:

  • To quantify the contributions of changes in cardiovascular risk factors versus medical and surgical treatments to the observed decrease in CHD mortality in Italy.
  • To provide insights for future prevention and treatment strategies for cardiovascular disease.

Main Methods:

  • Utilized a validated mathematical model to analyze data from 1980 to 2000 in Italy.
  • Integrated data from published trials, meta-analyses, official statistics, longitudinal studies, and national surveys.
  • Partitioned the difference between observed and expected CHD deaths into contributions from risk factor changes and treatment interventions.

Main Results:

  • The age-adjusted CHD mortality rate among individuals aged 25–84 years decreased, leading to 42,930 fewer CHD deaths in 2000.
  • Approximately 55% of the CHD mortality reduction was attributed to changes in cardiovascular risk factors.
  • About 40% of the decrease in CHD mortality was attributed to medical and surgical treatments.

Conclusions:

  • Over half of the decline in CHD mortality in Italy was driven by reductions in major risk factors, particularly cholesterol and blood pressure levels.
  • Evidence-based medical therapies accounted for less than half of the observed mortality decrease.
  • These findings underscore the critical role of risk factor modification in reducing cardiovascular disease burden and inform future public health planning.